INFORMATION MOUNJARO (tirzepatide) 10mg/0.6ml KwikPen is a onceweekly, singleneedle subcutaneous injection supplied as a singlepatientuse pen that delivers four fixed 10mg doses for adults with type 2 diabetes who have already titrated through lower strengths and need additional glycaemic and weight loss support
You can expect these changes in appetite, weight, and blood sugar levels over one month: What to expect after 1 month
Since semaglutide is often used to manage blood sugar levels in type 2 diabetes, discontinuing the drug can result in difficulties in blood sugar control, potentially necessitating alternative therapeutic strategies to maintain glycemic stability
Same injection process
We strive to equip you with the knowledge, tools, insight, and resources needed for effective weight loss
Understanding DSIP before you dose Before calculating your first injection, you need to understand what makes DSIP fundamentally different from other sleep interventions